Interpreting Osteogenesis Imperfecta Variants of Uncertain Significance in the Context of Physical Abuse: A Case Series

Abstract

Unexplained childhood fracture(s) warrant consideration of physical abuse and osteogenesis imperfecta (OI). Genetic OI testing may identify “variants of unknown significance (VUS).” Interpretation of VUS in context of potential abuse may have protective, criminal, and medical impacts. This case series explores practices regarding clinicians' interpretation of VUS during child abuse evaluations. Variability was noted regarding factors considered for interpreting clinical significance. Based on these cases, recommendations for careful and thorough evaluation are detailed, including proposed use of a limited follow-up skeletal survey in 3 months, as a consideration to assess healing of prior fractures and to look for any additional injuries.

Keywords

variant of unknown significance - osteogenesis imperfect - child physical abuse

• References

• 1 Van Dijk FS, Sillence DO. Osteogenesis imperfecta: clinical diagnosis, nomenclature and severity assessment. Am J Med Genet A 2014; 164 (06) 1470-1481
• 2 Jenny C. ; Committee on Child Abuse and Neglect. Evaluating infants and young children with multiple fractures. Pediatrics 2006; 118 (03) 1299-1303
• 3 Singh Kocher M, Dichtel L. Osteogenesis imperfecta misdiagnosed as child abuse. J Pediatr Orthop B 2011; 20 (06) 440-443
• 4 Servaes S, Brown SD, Choudhary AK. , et al. The etiology and significance of fractures in infants and young children: a critical multidisciplinary review. Pediatr Radiol 2016; 46 (05) 591-600
• 5 Marlowe A, Pepin MG, Byers PH. Testing for osteogenesis imperfecta in cases of suspected non-accidental injury. J Med Genet 2002; 39 (06) 382-386
• 6 Pereira EM. Clinical perspectives on osteogenesis imperfecta versus non-accidental injury. Am J Med Genet C Semin Med Genet 2015; 169 (04) 302-306
• 7 Pepin MG, Byers PH. What every clinical geneticist should know about testing for osteogenesis imperfecta in suspected child abuse cases. Am J Med Genet C Semin Med Genet 2015; 169 (04) 307-313
• 8 Zarate YA, Clingenpeel R, Sellars EA. , et al. COL1A1 and COL1A2 sequencing results in cohort of patients undergoing evaluation for potential child abuse. Am J Med Genet A 2016; 170 (07) 1858-1862
• 9 Bell J, Bodmer D, Sistermans E, Ramsden SC. UK Clinical Molecular Genetics Society and the Dutch Society of Clinical Genetic Laboratory Specialists. Practice guidelines for the Interpretation and Reporting of Unclassified Variants (UVs) in Clinical Molecular Genetics. Available at: http://www.bsgm.org.uk/media/774848/uv_guidelines_ratified.pdf [Ratified: 2007 and 2008]
• 10 Wallis Y, Payne S, McAnulty C. , et al. Association for Clinical Genetic Science part of the British Society for Genetics Medicine. Practice guidelines for the evaluation of pathogenicity and the reporting of sequence variants in clinical molecular genetics. Available at: http://www.acgs.uk.com/media/774853/evaluation_and_reporting_of_sequence_variants_bpgs_june_2013_-_finalpdf.pdf [Updated: 2013]
• 11 Richards S, Aziz N, Bale S. , et al; ACMG Laboratory Quality Assurance Committee. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 2015; 17 (05) 405-424
• 12 van Dijk FS, Byers PH, Dalgleish R. , et al. EMQN best practice guidelines for the laboratory diagnosis of osteogenesis imperfecta. Eur J Hum Genet 2012; 20 (01) 11-19
• 13 Youngblom E, Murray ML, Byers PH. Current practices and the provider perspectives on inconclusive genetic test results for osteogenesis imperfecta in children with unexplained fractures: ELSI implications. J Law Med Ethics 2016; 44 (03) 514-519
• 14 Adam MP, Ardinger HH, Pagon RA. , et al, eds. COL1A1/2-related osteogenesis imperfecta. Seattle, WA: Gene Reviews(R) [Internet] University of Washington, Seattle University of Washington; ; 1993–2018. Available at: https://www.ncbi.nlm.nih.gov/books/NBK138604/ . [Updated 2013].
• 15 Steiner RD, Pepin M, Byers PH. Studies of collagen synthesis and structure in the differentiation of child abuse from osteogenesis imperfecta. J Pediatr 1996; 128 (04) 542-547
• 16 Hansen KK, Keeshin BR, Flaherty E. , et al. Sensitivity of the limited view follow-up skeletal survey. Pediatrics 2014; 134 (02) 242-248
• 17 Kleinman PK. Diagnostic Imaging of Child Abuse. Cambridge, UK: Cambridge University Press; 2015
• 18 Nykamp K, Anderson M, Powers M. , et al; Invitae Clinical Genomics Group. Sherloc: a comprehensive refinement of the ACMG-AMP variant classification criteria. Genet Med 2017; 19 (10) 1105-1117
• 19 Lindahl K, Åström E, Rubin CJ. , et al. Genetic epidemiology, prevalence, and genotype-phenotype correlations in the Swedish population with osteogenesis imperfecta. Eur J Hum Genet 2015; 23 (08) 1042-1050
• 20 Greeley CS, Donaruma-Kwoh M, Vettimattam M, Lobo C, Williard C, Mazur L. Fractures at diagnosis in infants and children with osteogenesis imperfecta. J Pediatr Orthop 2013; 33 (01) 32-36
• 21 Jackson SC, Odiaman L, Card RT, van der Bom JG, Poon MC. Suspected collagen disorders in the bleeding disorder clinic: a case-control study. Haemophilia 2013; 19 (02) 246-250
• 22 Mondal RK, Mann U, Sharma M. Osteogenesis imperfecta with bleeding diathesis. Indian J Pediatr 2003; 70 (01) 95-96
• 23 Ganesh A, Jenny C, Geyer J, Shouldice M, Levin AV. Retinal hemorrhages in type I osteogenesis imperfecta after minor trauma. Ophthalmology 2004; 111 (07) 1428-1431
• 24 Maguire SA, Watts PO, Shaw AD. , et al. Retinal haemorrhages and related findings in abusive and non-abusive head trauma: a systematic review. Eye (Lond) 2013; 27 (01) 28-36
• 25 Albayram S, Kizilkilic O, Yilmaz H, Tuysuz B, Kocer N, Islak C. Abnormalities in the cerebral arterial system in osteogenesis imperfecta. Am J Neuroradiol 2003; 24 (04) 748-750
• 26 Cole WG, Lam TP. Arachnoid cyst and chronic subdural haematoma in a child with osteogenesis imperfecta type III resulting from the substitution of glycine 1006 by alanine in the pro alpha 2(I) chain of type I procollagen. J Med Genet 1996; 33 (03) 193-196
• 27 Groninger A, Schaper J, Messing-Juenger M, Mayatepek E, Rosenbaum T. Subdural hematoma as clinical presentation of osteogenesis imperfecta. Pediatr Neurol 2005; 32 (02) 140-142
• 28 Lazoritz S, Palusci VJ, Plotkin H. How do child abuse pediatricians diagnose OI? A survey of the AAP Section on Abuse and Neglect. Presented at: 3rd Annual Meeting of the Helfer Society; September 19, 2003; Montebello, Quebec, Canada